Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine.
出版信息
J Emerg Med. 2022 Mar;62(3):426. doi: 10.1016/j.jemermed.2021.10.038. Epub 2021 Oct 29.
Abstract
摘要
相似文献
1
Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine.
J Emerg Med. 2022 Mar;62(3):426. doi: 10.1016/j.jemermed.2021.10.038. Epub 2021 Oct 29.
2
Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine.
J Clin Neuromuscul Dis. 2021 Dec 1;23(2):115-116. doi: 10.1097/CND.0000000000000383.
3
Bilateral facial palsy with paresthesias, variant of Guillain-Barré syndrome following COVID-19 vaccine: A case series of 9 patients.
Neuromuscul Disord. 2022 Jul;32(7):572-574. doi: 10.1016/j.nmd.2022.05.003. Epub 2022 May 11.
4
COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination.
Rev Clin Esp (Barc). 2021 Nov;221(9):555-557. doi: 10.1016/j.rceng.2021.05.002. Epub 2021 Sep 27.
5
Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
Clin Neurol Neurosurg. 2021 Sep;208:106887. doi: 10.1016/j.clineuro.2021.106887. Epub 2021 Aug 13.
6
Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.
Acta Neurol Belg. 2022 Oct;122(5):1369-1371. doi: 10.1007/s13760-021-01838-4. Epub 2021 Nov 12.
7
Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
Emerg Infect Dis. 2022 May;28(5):1079-1080. doi: 10.3201/eid2805.212145.
8
[Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
Rev Fac Cien Med Univ Nac Cordoba. 2021 Dec 28;78(4):405-407. doi: 10.31053/1853.0605.v78.n4.32392.
9
Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database.
JAMA Intern Med. 2021 Sep 1;181(9):1243-1245. doi: 10.1001/jamainternmed.2021.2219.
10
Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis.
Ann Neurol. 2022 Jan;91(1):162-163. doi: 10.1002/ana.26258. Epub 2021 Nov 12.
本文引用的文献
1
Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
J Emerg Med. 2021 Dec;61(6):e141-e145. doi: 10.1016/j.jemermed.2021.07.062. Epub 2021 Aug 7.
2
Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211020833. doi: 10.1177/10760296211020833.
3
Safety of Therapeutic Plasma Exchange for the Treatment of Guillain-Barré Syndrome in Polycythemia Vera.
Neurologist. 2018 Nov;23(6):185-187. doi: 10.1097/NRL.0000000000000197.
4
Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion.
Pediatrics. 1982 Apr;69(4):419-25.
Zotero 插件